+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Side Effects of Drugs Annual, Vol 30

  • ID: 1763350
  • Book
  • July 2008
  • Region: Global
  • 672 Pages
  • Elsevier Science and Technology
1 of 3
The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the informative, by critically interpreting it, and by pointing to whatever is misleading.

- Provides a critical yearly survey of new data and trends in the side effects of drugs- Each drug article contains case histories- Contains detailed information on drug-drug interactions

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Note: Product cover images may vary from those shown
2 of 3
Special Reviews
Cumulative Index of Special Reviews, Annuals 13
DoTS Classification of Adverse Drug Reactions
How to use this book
Central nervous system stimulants and drugs that suppress appetite
Antidepressant drugs
Drugs of abuse
Hypnotics and sedatives
Antipsychotic drugs
Antiepileptic drugs
Opioid analgesics and narcotic antagonists
Anti-inflammatory and antipyretic analgesics and drugs used in gout
General anesthetics and therapeutic gases
Local anesthetics
Neuromuscular blocking agents and skeletal muscle relaxants
Drugs that affect autonomic functions or the extrapyramidal system
Dermatological drugs, topical agents and cosmetics
Antihistamines (H1 receptor antagonists)
Drugs acting on the respiratory tract
Positive inotropic drugs and drugs used in dysrhythmias
Beta-adrenoceptor antagonists and antianginal drugs
Drugs acting on the cerebral and peripheral circulations
Antihypertensive drugs
Metal antagonists
Antiseptic drugs and disinfectants
Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
Miscellaneous antibacterial drugs
Antifungal drugs
Antiprozotoal Drugs
Antiviral drugs
Drugs used in tuberculosis and leprosy
Antihelminthic drugs
Blood, blood components, plasma and plasma products
Formulations used in nutrition
Drugs affecting blood coagulation, fibrinolysis, and hemostasis
Gastrointestinal drugs
Drugs that act on the immune system: cytokines and monoclonal antibodies
Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
Corticotrophins, corticosteroids, and prostaglandins
Sex hormones and related compounds, including hormonal contraceptives
Thyroid hormones, iodine, and antithyroid drugs
Insulin, other hypoglycemic drugs, and glucagon
Miscellaneous hormones
Drugs that affect lipid metabolism
Cytostatic drugs
Radiological contrast agents
Drugs used in ocular treatment
Treatments used in complementary and alternative medicine
Miscellaneous drugs and materials, medical devices and techniques
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Aronson, Jeffrey K.
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Note: Product cover images may vary from those shown